Sign up to save your podcasts
Or
Share Tech On Drugs - Se2Ep3 - Dr. Yair Benita
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Tech On Drugs - Se2Ep3 - Dr. Yair Benita
This episode was recorded in the beautiful Island of Crete, at CytoReason's employee conference, the CytoSummit.
CytoReason's Co-founder Shai Shen-Orr hosts AION Labs CTO Yair Benita.
Yair is a computational biologist who spent more than 20 years studying biology through omics and clinical data in an effort to piece together mechanisms of human disease. He’s been leading computational teams in drug discovery at CytoReason, Compugen, and Merck.
In this candid conversation with Shai, Yair reflects on the highs and lows of his professional journey over the past two decades, as well as the broader industry landscape.
Key questions discussed include:
CytoReason's Co-founder Shai Shen-Orr hosts AION Labs CTO Yair Benita.
Yair is a computational biologist who spent more than 20 years studying biology through omics and clinical data in an effort to piece together mechanisms of human disease. He’s been leading computational teams in drug discovery at CytoReason, Compugen, and Merck.
In this candid conversation with Shai, Yair reflects on the highs and lows of his professional journey over the past two decades, as well as the broader industry landscape.
Key questions discussed include:
- What major shift did Keytruda's development introduce to the industry?
- How did pharma's 'Kodak moment’ come about?
- What needs to happen in pharma R&D so data is no longer JUST supporting decisions, but actually driving them?
View all episodes
By CytoReasonThis episode was recorded in the beautiful Island of Crete, at CytoReason's employee conference, the CytoSummit.
CytoReason's Co-founder Shai Shen-Orr hosts AION Labs CTO Yair Benita.
Yair is a computational biologist who spent more than 20 years studying biology through omics and clinical data in an effort to piece together mechanisms of human disease. He’s been leading computational teams in drug discovery at CytoReason, Compugen, and Merck.
In this candid conversation with Shai, Yair reflects on the highs and lows of his professional journey over the past two decades, as well as the broader industry landscape.
Key questions discussed include:
CytoReason's Co-founder Shai Shen-Orr hosts AION Labs CTO Yair Benita.
Yair is a computational biologist who spent more than 20 years studying biology through omics and clinical data in an effort to piece together mechanisms of human disease. He’s been leading computational teams in drug discovery at CytoReason, Compugen, and Merck.
In this candid conversation with Shai, Yair reflects on the highs and lows of his professional journey over the past two decades, as well as the broader industry landscape.
Key questions discussed include:
- What major shift did Keytruda's development introduce to the industry?
- How did pharma's 'Kodak moment’ come about?
- What needs to happen in pharma R&D so data is no longer JUST supporting decisions, but actually driving them?
More shows like Tech on Drugs with Shai Shen-Orr
View all
Pod Save America
86,250 Listeners
אחד ביום
299 Listeners